Protective Effects of Araloside C Against Myocardial Ischaemia/reperfusion Injury: Potential Involvement of Heat Shock Protein 90.

Min Wang,Yu Tian,Yu-yang Du,Gui-bo Sun,Xu-dong Xu,Hai Jiang,Hui-bo Xu,Xiang-bao Meng,Jing-yi Zhang,Shi-lan Ding,Miao-di Zhang,Ming-hua Yang,Xiao-bo Sun
DOI: https://doi.org/10.1111/jcmm.13107
2017-01-01
Journal of Cellular and Molecular Medicine
Abstract:The present study was designed to investigate whether Araloside C, one of the major triterpenoid compounds isolated from Aralia elata known to be cardioprotective, can improve heart function following ischaemia/reperfusion (I/R) injury and elucidate its underlying mechanisms. We observed that Araloside C concentration-dependently improved cardiac function and depressed oxidative stress induced by I/R. Similar protection was confirmed in isolated cardiomyocytes characterized by maintaining Ca2+ transients and cell shortening against I/R. Moreover, the potential targets of Araloside C were predicted using the DDI-CPI server and Discovery Studio software. Molecular docking analysis revealed that Araloside C could be stably docked into the ATP/ADP-binding domain of the heat shock protein 90 (Hsp90) protein via the formation of hydrogen bonds. The binding affinity of Hsp90 to Araloside C was detected using nanopore optical interferometry and yielded KD values of 29 μM. Araloside C also up-regulated the expression levels of Hsp90 and improved cell viability in hypoxia/reoxygenation-treated H9c2 cardiomyocytes, whereas the addition of 17-AAG, a pharmacologic inhibitor of Hsp90, attenuated Araloside C-induced cardioprotective effect. These findings reveal that Araloside C can efficiently attenuate myocardial I/R injury by reducing I/R-induced oxidative stress and [Ca2+ ]i overload, which was possibly related to its binding to the Hsp90 protein.
What problem does this paper attempt to address?